CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Kidney Cancer Awareness Month: 2022 Immunotherapy Research Updates

    This March for Kidney Cancer Awareness Month, discover the patient perspectives, clinical trials, and progress for a…

    March 9, 2022| CRI Staff
  • Richard Catlett

    Richard Catlett’s Immunotherapy Story

    Kidney Cancer |  Diagnosed 2007 When I went in to get my results from the study doctor, he…
    April 27, 2021| CRI Staff
  • Kidney Cancer Awareness Month: 2021 Immunotherapy Research Updates

    This March for Kidney Cancer Awareness Month, we look at new research, new treatments, and how we’re…

    March 7, 2021| CRI Staff
  • Kidney Cancer and Immunotherapy with Dr. Saby George at the 2020 CRI Virtual Immunotherapy Patient Summit

    Dr. Saby George discusses the latest updates in immunotherapy for kidney cancer at the 2020 CRI Virtual…

    January 11, 2021| Caroline Offit
  • Kidney Cancer Awareness Month: 2020 Immunotherapy Research Update

    Exciting immunotherapy combinations, lifesaving clinical trials, and how we’re working toward a future immune to kidney cancer.

    March 12, 2020| CRI Staff
  • Rick

    Rick’s Immunotherapy Story

    Kidney Cancer |  Diagnosed 2016 They use the term ‘super-responder,’ I like to think of myself as super-cured.”…
    July 2, 2019| CRI Staff
  • Checkpoint Immunotherapy Combination Approved for First-line Treatment of Advanced Kidney Cancer

    The combination of checkpoint immunotherapies against PD-1 and CTLA-4 significantly improved survival and response rates compared to…

    April 16, 2018| Arthur N. Brodsky, PhD
  • Philip Prichard

    Philip P’s Immunotherapy Story

    Kidney Cancer |  Diagnosed 2012 I feel like I can see past tomorrow. Philip’s Story In 2012, lifelong…
    March 15, 2017| CRI Staff
  • Dave Healy

    Dave Healy’s Immunotherapy Story

    Kidney Cancer |  Diagnosed 2009 It’s like three little pin pricks just underneath the skin. That’s about it….
    March 15, 2017| CRI Staff
1 2
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute